<?xml version="1.0" encoding="utf-8"?>
<File id="56">
  <Title><![CDATA[<p>Did the protective efficacy wane more rapidly in infants 6-12 weeks of age?</p>]]></Title>
  <HtmlTextKey><![CDATA[]]></HtmlTextKey>
  <HtmlText><![CDATA[<p>There is no evidence that the pattern of waning is different in children and in infants, but the starting point of level of protection post dose-3 is lower in infants than in children, resulting in lower VE estimates and 95%CI overlapping 0 for efficacy against more severe and less frequent forms of the disease at month 18.</p>]]></HtmlText>
  <Topic>EFFICACY</Topic>
  <SubTopic>LONG-TERM EFFICACY</SubTopic>
  <References><![CDATA[]]></References>
  <pdf>xml/content/56/56.pdf</pdf>
  <docx>xml/content/56/56.docx</docx>
  <contentLastUpdated>2014-03-03</contentLastUpdated>
  <RelatedFiles />
</File>